Foundations Investment Advisors, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Foundations Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	SELL	$120.42 - $169.29 $285,515 - $401,386	-2,371 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$127.18 - $173.91 $7,630 - $10,434	60 Added 2.6%	2,371 $397,000
Q4 2021 Jan 21, 2022	BUY	$159.56 - $209.29 $37,815 - $49,601	237 Added 11.43%	2,311 $341,000
Q3 2021 Oct 13, 2021	BUY	$169.75 - $207.73 $35,647 - $43,623	210 Added 11.27%	2,074 $411,000
Q2 2021 Jul 14, 2021	BUY	$128.63 - $176.89 $36,659 - $50,413	285 Added 18.05%	1,864 $329,000

Q1 2021 Apr 09, 2021	BUY	$126.83 - $175.69 $200,264 - $277,414	1,579 New	1,579 $222,000

584

104M

2.82M

1.75M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.5B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Foundations Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundations Investment Advisors, LLC with notifications on news.